PREVENTION OF AXONAL DAMAGE USING ANTIBODY BINDING TO AMYLOID BETA 1-42

摘要

The present invention relates to the prevention of neuronal axonal damage. More particularly, the present invention relates to the prevention neuronal axonal damage using binding members that selectively bind human amyloid beta 1-42 peptide (Aβ1-42), wherein the treatment of a patient with said binding member decreases the level of neurofilament light chain (NfL) in patients.